Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
- Details
- Category: Genzyme

European Medicines Agency maintains position on the continued use of Rotarix
- Details
- Category: GlaxoSmithKline

Ranibizumab significantly more effective than standard of care in treating vision loss due to DME
- Details
- Category: Novartis

Abbott to Become No. 1 Pharmaceutical Company in India
- Details
- Category: Abbott

Pfizer Global Manufacturing Announces Plans to Reconfigure its Global Plant Network
- Details
- Category: Pfizer

Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
- Details
- Category: Financial

Sanofi-aventis Announces the Creation of the "Sanofi Espoir" Corporate Foundation
- Details
- Category: Sanofi

More Pharma News ...
- Forest Laboratories and Nycomed Receive Complete Response Letter for Roflumilast
- Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center
- Positive pivotal results on escitalopram in Japan
- Covex S.A. creates 2000 jobs with the onset of a new agroindustrial project in Latin America
- Bayer receives approval for its new oral contraceptive in the U.S.
- RA.com Features Interactive Resource to Help People Living with Rheumatoid Arthritis
- New study results on Dulcolax® confirm efficacy and safety